Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease

Chinese Journal of Contemporary Pediatrics

Volumn 11, Issue 6, 2009, Pages 429-432

  Zhang, Shen Rong ^a   Zhang, Yuan Hai ^a   Xu, Qiang ^a   Qiu, Hui Xian ^a   Chen, Qi ^b  

^a THE SECOND AFFILIATED HOSPITAL AND YUYING CHILDREN S HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Brain natriuretic peptide; Child; Congenital heart disease; Heart failure, congestive; N terminal pro brain natriuretic peptide

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ARTICLE; BLOOD; CHILD; CONGENITAL HEART MALFORMATION; DIASTOLE; FEMALE; HEART; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; INFANT; MALE; PATHOPHYSIOLOGY; PRESCHOOL CHILD;

CHILD; CHILD, PRESCHOOL; DIASTOLE; FEMALE; HEART; HEART DEFECTS, CONGENITAL; HEART FAILURE; HUMANS; INFANT; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; VENTRICULAR FUNCTION, LEFT;

EID: 69149087235     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain[J]. Nature, 1988, 332(6159):78-81. (Pubitemid 18083551)
2. Morrow DA, de Lemos JA, Blazing MA, Sabatine MS, Murphy SA, Jarolim P, et al. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease[J]. JAMA, 2005, 294(22):2866-2871. (Pubitemid 41785867)
3. Price JF, Thomas AK, Grenier M, Eidem BW, O'Brian Smith E, Denfield SW, et al. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction[J]. Circulationtion, 2006, 114(10):1063-1069. (Pubitemid 44358883)
4. Maher KO, Reed H, Cuadrado A, Simsic J, Mahle WT, Deguzman M, et al. B-type natriuretic peptide in the emergency diagnosis of critical heart disease in children[J]. Pediatrics, 2008, 121(6):e1484-e1488.
5. Aggarwal S, Pettersen MD, Bhambhani K, Gurczynski J, Thomas R, L'Ecuyer T. B-type natriuretic peptide as a marker for cardiac dysfunction in anthracycline-treated children[J]. Pediatr Blood Cancer, 2007, 49(6):812-816. (Pubitemid 47519518)
6. Nasser N, Perles Z, Rein AJ, Nir A. NT-proBNP as a marker for persistent cardiac disease in children with history of dilated cardiomyopathy and myocarditis[J]. Pediatr Cardiol, 2006, 27(1):87-90.
7. Reithmann C, Reber D, Kozlik-Feldmann R, Netz H, Pilz G, Welz A, et al. Post-recepter defect of adenylyl cyclase in severely failing myocardium from children with congenital heart disease[J]. Eur J Pharmacol, 1997, 330(1):79-86. (Pubitemid 27304036)
8. Läer S, Mir TS, Behn F, Eiselt M, Scholz H, Venzke A, et al. Carvedilol therapy in pediatric patients with congestive heart failure: a study investigating clinical and pharmacokinetic parameters[J]. Am Heart J, 2002, 143(5):916-922. (Pubitemid 34595354)
9. Zile MR, Gaasch WH, Carroll JD, Feldman MD, Aurigemma GP, Schaer GL, et al. Heart failure with a normal ejection fraction:is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure?[J]. Circulation, 2001, 104(7):779-782. (Pubitemid 32762675)
10. Ng LL, Loke I, Davies JE, Khunti K, Stone M, Abrams KR, et al. Identification of previously undiagnosed left ventricular systolic dysfunction: community screening using natriuretic peptides and electrocardiography[J]. Eur J Heart Fail, 2003, 5(6):775-782. (Pubitemid 38198065)
11. Hall C. Essential biochemistry and physiology of NT-proBNP[J]. Eur J Heart Fail, 2004, 6(3):257-260.
12. Yeo KT, Dumont KE, Brough T. Elecsys NT-ProBNP and BNP assays: are there analytically and clinically relevant differences?[J]. J Card Fail, 2005, 11(5 Suppl):s84-s88.
13. Mir TS, Marohn S, Läer S, Eiselt M, Grollmus O, Weil J, et al. Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure[J]. Pediatrics, 2002, 110(6):e76.
14. Seino Y, Ogawa A, Yamashita T, Fukushima M, Ogata K, Fukumoto H, et al. Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure[J]. Eur J Heart Fail, 2004, 6(3):295-300. (Pubitemid 38253048)
15. Chien TI, Chen HH, Kao JT. Comparison of Abbott AxSYM and Roche Elecsys 2010 for measurement of BNP and NT-proBNP[J]. Clin Chim Acta, 2006, 369(1):95-99.